Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death
Death receptors (DR4 and DR5) offer attractive targets for cancer treatment because cancer cell death can be induced by apoptotic signal upon binding of death ligands such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with death receptors. Cyclometalated iridium(III) complexes s...
Saved in:
| Main Authors: | Abdullah-Al Masum, Yosuke Hisamatsu, Kenta Yokoi, Shin Aoki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Bioinorganic Chemistry and Applications |
| Online Access: | http://dx.doi.org/10.1155/2018/7578965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unfinished debate: Why IPH-based metrics are still needed—An Editorial for “Signal intensity and volume of carotid intraplaque hemorrhage on magnetic resonance imaging and the risk of ipsilateral cerebrovascular events: the Plaque At RISK (PARISK) study”
by: Chun Yuan, et al.
Published: (2024-01-01) -
Luminescent Iridium–Terpyridine Complexes with Various Bis-Cyclometalated Ligands
by: Ko Ikeda, et al.
Published: (2025-01-01) -
Radiosensitization effect of iridium (III) complex on lung cancer cells via mitochondria apoptosis pathway
by: Yuru Pang, et al.
Published: (2025-03-01) -
Cationic antimicrobial peptide CC34 potential anticancer and apoptotic induction on cancer cells
by: Liqiang Dong, et al.
Published: (2025-05-01) -
Selective apoptosis induction by antimicrobial peptide TP4 in MCF-7 breast cancer cells
by: Rashid Alijani Ardeshir, et al.
Published: (2025-04-01)